These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 7972238

  • 1. The N-myc oncoprotein is a transcriptional activator and associates with max and RB1 proteins.
    Wenzel A, Cziepluch C, Schürmann J, Schwab M.
    Prog Clin Biol Res; 1994; 385():59-66. PubMed ID: 7972238
    [No Abstract] [Full Text] [Related]

  • 2. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
    Fieber W, Schneider ML, Matt T, Kräutler B, Konrat R, Bister K.
    J Mol Biol; 2001 Apr 13; 307(5):1395-410. PubMed ID: 11292350
    [Abstract] [Full Text] [Related]

  • 3. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
    Raschella G, Romeo A, Negroni A, Pucci S, Dominici C, Castello MA, Bevilacqua P, Felsani A, Calabretta B.
    Cancer Res; 1994 Apr 15; 54(8):2251-5. PubMed ID: 8174135
    [Abstract] [Full Text] [Related]

  • 4. Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain.
    Crouch DH, Fisher F, La Rocca SA, Goding CR, Gillespie DA.
    Nucleic Acids Res; 2005 Apr 15; 33(16):5235-42. PubMed ID: 16166655
    [Abstract] [Full Text] [Related]

  • 5. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
    Crouch DH, Fisher F, Clark W, Jayaraman PS, Goding CR, Gillespie DA.
    Oncogene; 1993 Jul 15; 8(7):1849-55. PubMed ID: 8510929
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K, Anand G, Yin X, Grove L, Prochownik EV.
    Oncogene; 1998 Mar 05; 16(9):1149-59. PubMed ID: 9528857
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
    Lüscher B, Larsson LG.
    Oncogene; 1999 May 13; 18(19):2955-66. PubMed ID: 10378692
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
    Mauleon I, Lombard MN, Muñoz-Alonso MJ, Cañelles M, Leon J.
    Mol Carcinog; 2004 Feb 13; 39(2):85-90. PubMed ID: 14750213
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of two distinct homologues of Xenopus Max during early development.
    King MW, Blackwood EM, Eisenman RN.
    Cell Growth Differ; 1993 Feb 13; 4(2):85-92. PubMed ID: 8494787
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
    Naderi S, Blomhoff HK.
    J Cell Physiol; 1999 Jan 13; 178(1):76-84. PubMed ID: 9886493
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.